PCSK9 inhibitors: Studies needed to prove efficacy and safety in chronic kidney disease
Chronic kidney disease (CKD) is associated with a substantially increased risk for the development of atherosclerotic cardiovascular disease (CVD). Accordingly, cardiovascular mortality is increased even in the earliest stages ...
Jun 14, 2019
0
1